A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

Tuszynski, Mark H, Thal, Leon, Pay, Mary, Salmon, David P, U, Hoi Sang, Bakay, Roy, Patel, Piyush, Blesch, Armin +10 more·2005·Nature Medicine
DOI 10.1038/nm1239

Cited by (1,001)

Items 201–300 of 1,001

  1. NGF-conjugated iron oxide nanoparticles promote differentiation and outgrowth of PC12 cells
    Michal Marcus, Hadas Skaat, N. Alon, Shlomo Margel, Orit Shefi · 2014 · Nanoscale
  2. The ethics of informed consent in Alzheimer disease research
    Scott Y. H. Kim · 2011 · Nature Reviews Neurology
  3. Dysregulation of Neurotrophic and Haematopoietic Growth Factors in Alzheimer’s Disease: From Pathophysiology to Novel Treatment Strategies
    Kateryna Sopova, Katerina Gatsiou, Konstantinos Stellos, Christoph Laske · 2014 · Current Alzheimer Research
  4. Brain organoids: a next step for humanized Alzheimer’s disease models?
    Yannis Gerakis, Claudio A. Hetz · 2019 · Molecular Psychiatry
  5. Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development
    Dagmar E. Ehrnhoefer, Bibiana K. Y. Wong, Michael R. Hayden · 2011 · Nature Reviews Drug Discovery
  6. Nerve maintenance and regeneration in the damaged cochlea
    Seiji Bruce Shibata, Cameron L. Budenz, Sara A. Bowling, Bryan E. Pfingst, Yehoash Raphael · 2011 · Hearing Research
  7. Midlife predictors of Alzheimer's disease
    Barbara B. Bendlin, Cynthia M. Carlsson, Carey Elizabeth Gleason, Sterling C. Johnson, Aparna Sodhi, Catherine L. Gallagher, Luigi Puglielli, Corinne D. Engelman, Michele L. Ries, Guofan Xu et al. · 2009 · Maturitas
  8. Human stem cells for CNS repair
    Rike Zietlow, Emma L. Lane, Stephen B. Dunnett, Anne Rosser · 2007 · Cell and Tissue Research
  9. Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound
    Stavarache, Mihaela A., Petersen, Nicholas, Jurgens, Eric M., Milstein, Elizabeth R., Rosenfeld, Zachary B., Ballon, Douglas J., Kaplitt, Michael G. · 2019 · Journal of Neurosurgery
  10. Nerve growth factor and burn wound healing: Update of molecular interactions with skin cells.
    Mahmoud G. El Baassiri, Laura Dosh, Hanine Haidar, A. Gerges, Silma Baassiri, A. Leone, F. Rappa, A. Jurjus · 2022 · Burns
  11. BDNF-, IGF-1- and GDNF-Secreting Human Neural Progenitor Cells Rescue Amyloid β-Induced Toxicity in Cultured Rat Septal Neurons
    Narisorn Kitiyanant, Yindee Kitiyanant, Clive Niels Svendsen, Wipawan Thangnipon · 2011 · Neurochemical Research
  12. Neurotrophin Signaling via Long-Distance Axonal Transport
    Praveen D. Chowdary, Dung L. Che, Bianxiao Cui · 2012 · Annual Review of Physical Chemistry
  13. Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy
    Subrata Pramanik, Yanuar Alan Sulistio, Klaus Heese · 2016 · Molecular Neurobiology
  14. Magnetic Field-Assisted Gene Delivery: Achievements and Therapeutic Potential
    José I. Schwerdt, Gerardo Fabián Goya, M. Pilar Calatayud, Claudia Beatriz Hereñú, Paula Cecilia Reggiani, Rodolfo Gustavo Goya · 2012 · Current Gene Therapy
  15. Rodent Models of Amyloid-Beta Feature of Alzheimer’s Disease: Development and Potential Treatment Implications
    Chi Him Poon, Yingyi Wang, Man‐Lung Fung, Chengfei Zhang, Lee Wei Lim · 2020 · Aging and Disease
  16. Photoresponsive materials for intensified modulation of Alzheimer's amyloid-β protein aggregation: A review
    Wei Liu, Xiaoyan Dong, Yang Liu, Yan Ping Sun · 2021 · Acta Biomaterialia
  17. Efficient Gene Transfer via Retrograde Transport in Rodent and Primate Brains Using a Human Immunodeficiency Virus Type 1-Based Vector Pseudotyped with Rabies Virus Glycoprotein
    Shigeki Kato, Ken‐ichi Inoue, Kenta Kobayashi, Yasunobu Yasoshima, Shigehiro Miyachi, Satoshi Inoue, Hideki Hanawa, Takashi Shimada, Masahiko Takada, Kazuto Kobayashi · 2007 · Human Gene Therapy
  18. Intranasal “painless” Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice
    Simona Capsoni, Sara Marinelli, Marcello Ceci, Domenico Vignone, Gianluca Amato, Francesca Malerba, Francesca Paoletti, Giovanni Meli, Alessandro Viegi, Flaminia Pavone et al. · 2012 · PLoS ONE
  19. Intranasal delivery of therapeutic proteins for neurological diseases
    Francesca Malerba, Francesca Paoletti, Simona Capsoni, Antonino Cattaneo · 2011 · Expert Opinion on Drug Delivery
  20. Bridging Physiology and Pathology in AD
    Dohoon Kim, Li‐Huei Tsai · 2009 · Cell
  21. Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders.
    A. Reddy, Janani Ravichandran, Nurgul Carkaci-Salli · 2020 · Biochimica et Biophysica Acta - Molecular Basis of Disease
  22. Endogenous Aβ causes cell death via early tau hyperphosphorylation
    Giuseppina Amadoro, Veronica Corsetti, Maria Teresa Ciotti, Fulvio Florenzano, Simona Capsoni, G. Amato, Pietro Calissano · 2009 · Neurobiology of Aging
  23. Long-term Delivery of Nerve Growth Factor by Encapsulated Cell Biodelivery in the Göttingen Minipig Basal Forebrain
    Lone Fjord‐Larsen, Philip Kusk, Jens Tornøe, Bengt Juliusson, Malene Torp, Carsten Reidies Bjarkam, Mette Slot Nielsen, Aase Handberg, Jens Christian Hedemann Sørensen, Lars U. Wahlberg · 2010 · Molecular Therapy
  24. Surrogate consent for dementia research
    Scott Y. H. Kim, H. M. Kim, Kenneth M. Langa, Jason H. Karlawish, David S. Knopman, Paul S. Appelbaum · 2009 · Neurology
  25. Nerve growth factor, pain, itch and inflammation: lessons from congenital insensitivity to pain with anhidrosis
    Yasuhiro Indo · 2010 · Expert Review of Neurotherapeutics
  26. Ex vivo gene therapy for the treatment of neurological disorders
    Genevíève Gowing, Soshana P. Svendsen, Clive N. Svendsen · 2017 · Progress in brain research
  27. Genetic therapy for the nervous system
    William J. Bowers, Xandra O. Breakefield, Miguel Sena‐Esteves · 2011 · Human Molecular Genetics
  28. Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next?
    Raymond T. Bartus, Eugene M. Johnson · 2016 · Neurobiology of Disease
  29. Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating “clinical proof-of-concept” for AAV-neurturin (CERE-120) in Parkinson's disease
    Raymond T. Bartus, Tiffany L. Baumann, Lamar Brown, Brian R. Kruegel, Jeffrey M. Ostrove, Christopher D. Herzog · 2012 · Neurobiology of Aging
  30. The septo-hippocampal system, learning and recovery of function
    Niewiadomska, Grazyna, Baksalerska-Pazera, Marta, Riedel, Gernot · 2009 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  31. Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease
    Marwa A. Aboukhatwa, Laura E. Dosanjh, Yuan Luo · 2010 · Molecular Neurodegeneration
  32. Gene therapy for neurological disorders
    Chi‐Jing Choong, Kousuke Baba, Hideki Mochizuki · 2015 · Expert Opinion on Biological Therapy
  33. Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease
    Stephen D. Ginsberg, Michael H. Malek‐Ahmadi, Melissa J. Alldred, Shaoli Che, Irina Elarova, Yinghua Chen, Freddy D. Jeanneteau, Thorsten M. Kranz, Moses V. Chao, Scott Counts et al. · 2017 · Hippocampus
  34. Risk of surgical delivery to deep nuclei: A meta‐analysis
    Jonathan Kimmelman, Katherine Duckworth, Tim Ramsay, Tiffini Voss, Bernard M. Ravina, Marina Elena Emborg · 2011 · Movement Disorders
  35. MicroRNA expression profiling of NGF-treated PC12 cells revealed a critical role for miR-221 in neuronal differentiation
    Nanako Hamada, Yasunori Fujita, Toshio Kojima, Aya Kitamoto, Yukihiro Akao, Yoshinori Nozawa, Masafumi Ito · 2012 · Neurochemistry International
  36. The Emerging Therapeutic Role of NGF in Alzheimer’s Disease
    Chao‐Jin Xu, Jun‐Ling Wang, Weilin Jin · 2016 · Neurochemical Research
  37. Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor
    Joseph Karl Eibl, Bridget C. Strasser, Gregory M. Ross · 2012 · Neurochemistry International
  38. The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer’s Disease Neuropathology
    Nadia Canu, Giuseppina Amadoro, Viviana Triaca, Valentina Latina, Valentina Sposato, Veronica Corsetti, Cinzia Severini, Maria Teresa Ciotti, Pietro Calissano · 2017 · International Journal of Molecular Sciences
  39. Gene therapy for late infantile neuronal ceroid lipofuscinosis: neurosurgical considerations
    Mark M. Souweidane, Justin F. Fraser, Lisa M. Arkin, Dolan Sondhi, Neil R. Hackett, Stephen M. Kaminsky, Linda Heier, Barry E. Kosofsky, Stefan Worgall, Ronald G. Crystal et al. · 2010 · Journal of Neurosurgery Pediatrics
  40. Melanocytes: A Window into the Nervous System
    Mina Yaar, Heeyoung Park · 2011 · Journal of Investigative Dermatology
  41. Neurotrophins - From Pathophysiology to Treatment in Alzheimers Disease
    Rainer Hellweg, Olaf Schulte‐Herbrüggen, Maria Christiane Jockers-Scherübl · 2008 · Current Alzheimer Research
  42. The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's Disease
    M. Florencia Iulita, A. Claudio Cuello · 2015 · Current Alzheimer Research
  43. Developing strategies for detection of gene doping
    Anna Baoutina, Ian E. Alexander, John E.J. Rasko, Kerry R. Emslie · 2007 · The Journal of Gene Medicine
  44. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer’s disease
    Ubhi, Kiren, Rockenstein, Edward, Vazquez‐Roque, Ruben, Mante, Michael, Inglis, Chandra, Patrick, Christina, Adame, Anthony, Fahnestock, Margaret, Doppler, Edith, Novak, Philip et al. · 2013 · Journal of Neuroscience Research
  45. The cholinergic system in subtypes of Alzheimer’s disease: an in vivo longitudinal MRI study
    Alejandra Machado, Daniel Ferreira, Michel J. Grothe, Helga Eyjolfsdottir, Per M. Almqvist, Lena Cavallin, Göran Lind, Göran Lind, Åke Seiger, Stefan Teipel et al. · 2020 · Alzheimer s Research & Therapy
  46. Cerebral dopamine neurotrophic factor improves long-term memory in APP/PS1 transgenic mice modeling Alzheimer's disease as well as in wild-type mice
    Susanna Kemppainen, Päivi Lindholm, Emilia Galli, Hanna-Maija Lahtinen, Henna Koivisto, Elina Hämäläinen, Märt Saarma, Heikki Tanila · 2015 · Behavioural Brain Research
  47. Collagen for brain repair: therapeutic perspectives
    Christian Humpel, Buket Uçar · 2018 · Neural Regeneration Research
  48. Alzheimer’s disease: biological aspects, therapeutic perspectives and diagnostic tools
    Marta Di Carlo, Daniela Giacomazza, Pier Luigi San Biagio · 2012 · Journal of Physics Condensed Matter
  49. Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective
    Dur e Nayab, Fakhar ud Din, Hussain Ali, Warda Arooj Kausar, Shaiza Urooj, Maryam Zafar, Ibrahim Khan, Kanwal Shabbir, Gul Majid Khan · 2023 · Journal of Nanobiotechnology
  50. Doxycycline-regulated GDNF expression promotes axonal regeneration and functional recovery in transected peripheral nerve
    Antos Shakhbazau, Chandan B. Mohanty, Dzmitry Shcharbin, Maria J Bryszewska, Anne‐Marie Caminade, Jean‐Pierre Majoral, Jacob Alant, Rajiv Midha · 2013 · Journal of Controlled Release
  51. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease
    Azadeh Karami, Helga Eyjolfsdottir, Swetha Vijayaraghavan, Göran Lind, Per M. Almqvist, Ahmadul Kadir, Bengt Linderoth, Niels Andreasen, Kaj Blennow, Anders E. Wall et al. · 2015 · Alzheimer s & Dementia
  52. Humans as Superorganisms
    Peter Krämer, Paola Bressan · 2015 · Perspectives on Psychological Science
  53. Gene‐based treatment of motor neuron diseases
    Thais Federici, Nicholas M. Boulis · 2005 · Muscle & Nerve
  54. Nonhuman Primate Models of Neurodegenerative Disorders
    Marina Elena Emborg · 2017 · ILAR Journal
  55. Interpreting crosstalk between TNF-α and NGF: potential implications for disease
    Yoshinori Takei, Ronald Alfred Laskey · 2008 · Trends in Molecular Medicine
  56. Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review
    Ping‐Tao Tseng, Pao‐Yen Lin, Kun-Yu Tu, Yu‐Shian Cheng, Ching-Kuan Wu, Yen‐Wen Chen · 2015 · Neuropsychiatric Disease and Treatment
  57. Tyrosine kinase nerve growth factor receptor switches from prosurvival to proapoptotic activity via Abeta-mediated phosphorylation
    Carmela Matrone, Roberta Marolda, Stefania Ciafrè, Maria Teresa Ciotti, Delio Mercanti, Pietro Calissano · 2009 · Proceedings of the National Academy of Sciences
  58. Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment
    Rainer Hellweg, Peter Lohmann, Roman Huber, Alexander Kühl, Matthias W. Riepe · 2006 · Learning & Memory
  59. Alzheimer’s Disease and Stem Cell Therapy
    Sung Sik Choi, Sang‐Rae Lee, Seung Up Kim, Hong Jun Lee · 2014 · Experimental Neurobiology
  60. Comparative study on neuroprotective activities of fucoidans from Fucus vesiculosus and Undaria pinnatifida
    Mousa Alghazwi, Scott Darryl Smid, Samuel S. Karpiniec, Wei Yan Zhang · 2018 · International Journal of Biological Macromolecules
  61. Prospects for the application of mesenchymal stem cells in Alzheimer's disease treatment
    Forough Chakari-Khiavi, Sanam Dolati, Aref Chakari-Khiavi, Hossein Abbaszadeh, Leili Aghebati Maleki, Tannaz Pourlak, Amir Mehdizadeh, Mehdi Yousefi · 2019 · Life Sciences
  62. Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use
    S. Gavrilova, A. Alvarez · 2020 · Medicinal research reviews (Print)
  63. Concise Review: Can Stem Cells be Used to Treat or Model Alzheimer's Disease?
    Wesley W. Chen, Mathew M. Blurton-Jones · 2012 · Stem Cells
  64. rAAV Human Trial Experience
    Katherine A. High, Patrick R. Aubourg · 2011 · Methods in molecular biology
  65. Neurotrophic Factors in Neurodegeneration
    Armin Blesch · 2006 · Brain Pathology
  66. BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer’s disease
    Burke, Rebecca M., Norman, Timothy A., Haydar, Tarik F., Slack, Barbara E., Leeman, Susan E., Blusztajn, Jan Krzysztof, Mellott, Tiffany J. · 2013 · Proceedings of the National Academy of Sciences
  67. Precision medicine and drug development in Alzheimer’s disease: the importance of sexual dimorphism and patient stratification
    Hampel, Harald, Vergallo, Andrea, Giorgi, Filippo Sean, Kim, Seung Hyun, Depypere, Herman, Graziani, Manuela, Saidi, Amira, Nisticò, Robert, Lista, Simone · 2018 · Frontiers in Neuroendocrinology
  68. Systemic administration of fibroblast growth factor-2 (FGF2) reduces BACE1 expression and amyloid pathology in APP23 mice
    Loukia Katsouri, Azhaar Ashraf, Amy M. Birch, Kevin K.L. Lee, Nazanin Mirzaei, Magdalena Sastre · 2014 · Neurobiology of Aging
  69. Targeting Alzheimer's disease with gene and cell therapies
    Raúl Loera‐Valencia, Antonio Piras, Muhammad-Al-Mustafa Ismail, Shaffi Manchanda, Helga Eyjolfsdottir, Takaomi C. Saido, Jan Johansson, Maria Eriksdotter, Bengt G. Winblad, Per Nilsson · 2018 · Journal of Internal Medicine
  70. Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors
    Merienne, Nicolas, Douce, Juliette Le, Faivre, Emilie, Déglon, Nicole, Bonvento, Gilles · 2013 · Frontiers in Cellular Neuroscience
  71. The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor
    Simona Capsoni, Francesca Malerba, Nicola Maria Carucci, Caterina Rizzi, Chiara Criscuolo, Nicola Origlia, Mariantonietta Calvello, Alessandro Viegi, Giovanni Meli, Antonino Cattaneo · 2016 · Brain
  72. Autotransplantation of Bone Marrow-Derived Stem Cells as a Therapy for Neurodegenerative Diseases
    I. Kan, Eldad Melamed, Daniel Offen · 2007 · Handbook of experimental pharmacology
  73. Tissue Engineering and Regenerative Medicine: Perspectives and Challenges
    Van Thanh Hoang, Quyen Thi Nguyen, Trang Thi Kieu Phan, Trang H. Pham, Nhung Thi Hong Dinh, Le Phuong Hoang Anh, Lan T.M. Dao, Van Dat Bui, H. Dao, Duc Son Le et al. · 2025 · MedComm
  74. Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain
    Veronica Di Fausto, Marco Fiore, Paola Tirassa, Alessandro Lambìase, Luigi Aloe · 2007 · European Journal of Neuroscience
  75. Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy
    In-Kwon Han, Mi Young Kim, Hyang‐Min Byun, Tae Sun Hwang, Jung Mogg Kim, Kwang Woo Hwang, Tae Gwan Park, Woon-Won Jung, Taehoon Chun, Gil-Jae Jeong et al. · 2006 · Journal of Molecular Medicine
  76. Growth factors and cytokines/chemokines as surrogate biomarkers in cerebrospinal fluid and blood for diagnosing Alzheimer’s disease and mild cognitive impairment
    Lars Olson, Christian Humpel · 2009 · Experimental Gerontology
  77. Alzheimer's disease therapeutic research: the path forward
    Paul S. S. Aisen · 2009 · Alzheimer s Research & Therapy
  78. Role of Neurotrophic Factor Alterations in the Neurodegenerative Process in HIV Associated Neurocognitive Disorders
    Jerel Adam Fields, Wilmar Dumaop, Dianne Langford, Edward M. Rockenstein, Eliezer Masliah · 2014 · Journal of Neuroimmune Pharmacology
  79. Rivastigmine for Alzheimer’s disease
    Abhilash K. Desai, George Thomas Grossberg · 2005 · Expert Review of Neurotherapeutics
  80. Magnetic Targeting of Growth Factors Using Iron Oxide Nanoparticles
    Michal Marcus, Alexandra Smith, Ahmad Maswadeh, Ziv Shemesh, Idan Zak, Menachem Motiei, Hadas Schori, Shlomo Margel, Amos Sharoni, Orit Shefi · 2018 · Nanomaterials
  81. Human Olfactory Bulb Neural Stem Cells expressing hNGF Restore Cognitive Deficit in Alzheimer's Disease Rat Model
    Hany E. S. Marei, Amany Farag, Asma Althani, Nahla M. Afifi, Ahmed Abdelmaksoud, Samah Lashen, Shaymaa Rezk, Roberto Pallini M. D, Patrizia Casalbore, Carlo Cenciarelli · 2014 · Journal of Cellular Physiology
  82. Clinical Genetics of Alzheimer’s Disease
    Zhang‐Yu Zou, Changyun Liu, Chun‐Hui Che, Huapin Huang · 2014 · BioMed Research International
  83. Devices for cell transplantation into the central nervous system: Design considerations and emerging technologies
    Daniel A. Lim, MatthewB Potts, Matthew T. Silvestrini · 2013 · Surgical Neurology International
  84. Approaches for Neural Tissue Regeneration
    Loïc Binan, Abdellah Ajji, Grégory De Crescenzo, Mario Jolicœur · 2013 · Stem Cell Reviews and Reports
  85. Recent preclinical evidence advancing cell therapy for Alzheimer's disease
    Cesar V. Borlongan · 2012 · Experimental Neurology
  86. NGF‐Dependent Activation of TrkA Pathway: A Mechanism for the Neuroprotective Effect of Troxerutin in D‐Galactose‐Treated Mice
    Jun Lan Lu, Dong‐mei Wu, Bin Hu, Yuan‐Lin Zheng, Zi‐feng Zhang, Yong‐Jian Wang · 2010 · Brain Pathology
  87. Phenserine
    Jochen Klein · 2007 · Expert Opinion on Investigational Drugs
  88. Glia-Neurotrophic Factor Relationships: Possible Role in Pathobiology of Neuroinflammation-Related Brain Disorders
    Ewelina Pałasz, Anna Wilkaniec, Luiza Stanaszek, Anna Andrzejewska, Agata Adamczyk · 2023 · International Journal of Molecular Sciences
  89. Gene therapy and peripheral nerve repair: a perspective
    Stefan A. Hoyng, Fred de Winter, Martijn Rudolf Tannemaat, Bas Blits, Martijn J. A. Malessy, Joost Verhaagen · 2015 · Frontiers in Molecular Neuroscience
  90. Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: Biochemical and structural evidence
    Alessandro Lambìase, Lucia Pagani, Veronica Di Fausto, Valentina Sposato, Marco Coassin, Stefano Bonini, Luigi Aloe · 2006 · Brain Research
  91. Neural stem/progenitor cells in Alzheimer's disease.
    Gizem Tincer, Violeta Mashkaryan, Prabesh Bhattarai, Çağhan Kızıl · 2016 · Europe PMC (PubMed Central)
  92. Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration
    Yung‐Chih Kuo, Chang-Li Chen, Rajendiran Rajesh · 2019 · Acta Biomaterialia
  93. Gene therapy in epilepsy
    Véronique Riban, Helen L. Fitzsimons, Matthew J. During · 2008 · Epilepsia
  94. Neurotrophic factors promote cholinergic differentiation in human embryonic stem cell‐derived neurons
    Mats Nilbratt, Omar H. Porras, Amelia Marutle, Outi Hovatta, Agneta K. Nordberg · 2009 · Journal of Cellular and Molecular Medicine
  95. Microglial polarization in posttraumatic epilepsy: Potential mechanism and treatment opportunity
    Peravina Therajaran, John A. Hamilton, Terence John O'Brien, Nigel C. Jones, Idrish Yunus Ali · 2020 · Epilepsia
  96. Induction of neurite outgrowth in PC12 cells by artemisinin through activation of ERK and p38 MAPK signaling pathways
    Sarina, Yasuyuki Yagi, Oki Nakano, Toshihiro Hashimoto, Ko Kimura, Yoshinori Asakawa, Ming Zhong, Shizuo Narimatsu, Eiichi Gohda · 2012 · Brain Research
  97. Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before
    Cesare Mancuso, Raffaella Siciliano, Eugenio Barone, David Allan Butterfield, P Preziosi · 2011 · Expert Opinion on Investigational Drugs
  98. Nerve growth factor-mediated inhibition of apoptosis post-caspase activation is due to removal of active caspase-3 in a lysosome-dependent manner
    Katarzyna Mnich, Laura A. Carleton, Edel T. Kavanagh, Karen Doyle, Afshin Samali A, Adrienne M. Gorman · 2014 · Cell Death and Disease
  99. Disease-modifying drugs and Parkinson's disease
    H. Allain, Danièle Bentué‐Ferrer, Yvette Akwa · 2007 · Progress in Neurobiology
  100. Neuroprotective Role for Galanin in Alzheimer’s Disease
    Scott Counts, Sylvia E. Perez, Stephen D. Ginsberg, Elliott Jay Mufson · 2010 · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions